Class II · Moderate risk
Hylenex recombinant
cGMP Deviations: Temperature excursion
National Drug Code
Is NDC 18657-0117-04 recalled?
HYLENEX Recombinant · 4 BOX in 1 CARTON (18657-117-04) / 1 VIAL in 1 BOX (18657-117-02) / 1 mL in 1 VIAL (18657-117-01)
Yes — this exact package was recalled
1 FDA recall names the code 18657-0117-04 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Hyaluronidase
- Strength
- HYALURONIDASE (HUMAN RECOMBINANT) 150 [USP'U]/mL
- Form
- Injection, Solution · Subcutaneous
- Labeler
- Antares Pharma, Inc.
- Type
- Human Prescription Drug
- Product code
- 18657-0117
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.